| Financial Year |
March 31 2023 |
| Monetary Funds |
232,005,239.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
573,777,867.39 |
| Advances to Suppliers |
6,658,725.93 |
| Other Receivables |
18,204,219.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,550,195.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,469,558.80 |
| Total Current Assets |
1,101,597,491.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
453,254,566.55 |
| Under-construction Projects |
1,275,167.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
305,762,223.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,758,739.29 |
| Deferred Income Tax Assets |
9,639,813.80 |
| Other Non-Current Assets |
2,178,459,867.70 |
| Sub-Total of Non-Current Assets |
2,974,150,378.21 |
| Total Assets |
4,075,747,870.14 |
| Short-Term Loans |
434,950,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
512,186,348.52 |
| Accounts Payable |
498,332,287.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,364,943.67 |
| Taxes Payable |
89,845,640.88 |
| Interest Payable |
-- |
| Dividend Payable |
1,121,887.05 |
| Other payables |
246,795,616.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
238,125,853.57 |
| Other Current Liabilities |
5,405,146.23 |
| Sub-Total of Current Liabilities |
2,075,583,884.87 |
| Long-term Loans |
973,230,699.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
70,306,373.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
14,818,845.10 |
| Deferred Income Tax Liabilities |
3,628,616.25 |
| Other Non-Current Liabilities |
57,000,000.00 |
| Sub-Total of Non-Current Liabilities |
1,122,081,105.24 |
| Total Liabilities |
3,197,664,990.11 |
| Paid-In Capital(Or Share Stock) |
185,843,228.00 |
| Capital Surplus |
456,188,644.53 |
| Surplus Reserve |
35,827,983.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
39,829,594.21 |
| Minority Stockholder's Interest |
160,393,429.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
717,689,450.40 |
| Owner's Equity（Stockholder's Equity） |
878,082,880.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,075,747,870.14 |
